2011 International Meeting on the Molecular Biology of Hepatitis B Viruses

2011年乙型肝炎病毒分子生物学国际会议

• 批准号: 8122011
• 负责人: MICHAEL ROBEK
• 金额: $ 2万
• 依托单位: HEPATITIS B FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-01 至 2012-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8122011
• 关键词: Address; Animal Model; Antiviral Agents; Antiviral Therapy; Basic Science; Biochemistry; Biology; Biomedical Research; Cellular biology; Cessation of life; Cirrhosis; Communities; Development; Diabetes Mellitus; Digestive System Disorders; Discipline; Disease; Educational workshop; Financial Support; Foundations; Fund Raising; Funding; Gene Expression; Goals; Grant; Hepatitis B; Hepatitis B Virus; Hepatitis Delta Virus; Holidays; Home environment; Immunity; Immunology; Individual; Infection; Institutes; International; Joints; Kidney Diseases; Knowledge; Light; Liver Failure; Malignant Neoplasms; Minority; Mission; Modality; Molecular Biology; National Cancer Institute; National Institute of Allergy and Infectious Disease; National Institute of General Medical Sciences; Oral; Pathogenesis; Population; Postdoctoral Fellow; Primary carcinoma of the liver cells; Public Health; RNA Editing; Regulatory Element; Research Personnel; Resort; Schedule; Scientist; Senior Scientist; Series; Structure; Therapeutic; Time; Travel; Underrepresented Minority; United States National Institutes of Health; Universities; Vaccines; Viral; Virus; Virus Diseases; Virus Shedding; cost; gene therapy; graduate student; interest; lecturer; meetings; new therapeutic target; pathogen; posters; prophylactic; protein expression; vector; virology; virus host interaction

DESCRIPTION (provided by applicant): This proposal is a request for funding to support the travel expenses for young scientists to attend and participate in the 2011 International Meeting on the Molecular Biology of Hepatitis B Viruses, scheduled for October 9 - 12, 2011 at the Holiday Inn - In the Walt Disney World(R) Resort, Lake Buena Vista, FL. This meeting is the only forum that gathers the international community of researchers that focus on the hepatitis B virus (HBV) and the closely associated hepatitis delta virus (HDV). Approximately 25% of the world's population has been infected by HBV. Unfortunately, despite the availability of prophylactic vaccines, many new infections occur worldwide, mostly because of underutilization of the vaccine due to cost and other issues. Moreover, for the approximately 360 million people already chronically infected with HBV (approximately 15 million of whom are co-infected with HDV), the vaccine is of no therapeutic value. As a result, between 0.5 and 1 million people die of HBV/HDV every year worldwide. It is therefore imperative that basic research and the scientific exchange among those studying HBV/HDV continue, and the annual HBV meeting represents the venue at which this can occur. The 2011 meeting will uphold and enhance the traditional format and exchange with interaction and dialogue presented in 10 oral scientific sessions, 2 poster sessions as well as less structured "networking" time. A special focus of this meeting will be on virus-host interactions, with a particular emphasis on cell biology, antiviral immunity, and new therapeutic targets. This will be facilitated by three keynote addresses and a special workshop. As in the past, great effort has been made to minimize the cost of the meeting. Furthermore, the Hepatitis B Foundation has made a strong commitment to support this meeting since 2005, in terms of providing a permanent home for organizing the meeting and making its staff available for organizing the meeting and publicizing it, especially to universities with large numbers of underrepresented minorities. In order to allow the participation of junior and minority investigators, support from the NIH to help defray the meeting costs of junior scientists is requested. ) PUBLIC HEALTH RELEVANCE: The 2011 Molecular Biology of Hepatitis B Viruses Meeting is the next scheduled meeting in an annual series that has been held continuously since 1985. This is the only definitive meeting that brings together basic scientists in the field of hepatitis B virus (HBV) and hepatitis D virus (HDV) from throughout the world. HBV continues to be a major global and US public health problem with more than 360 million individuals chronically infected worldwide and with an annual rate of up to one million deaths due to HBV and HBV/HDV-induced liver failure, cirrhosis, and hepatocellular carcinoma. The meeting is a critical and internationally well recognized platform for continued exchange of information in basic research on HBV and HDV infections.

说明（由申请人提供）：本提案是一项资金申请，旨在支持年轻科学家出席和参加 2011 年乙型肝炎病毒分子生物学国际会议的旅费，该会议定于 2011 年 10 月 9 日至 12 日在假日酒店 - 位于佛罗里达州布埃纳维斯塔湖华特迪士尼世界度假村内。这次会议是唯一一个聚集了国际研究人员的论坛，他们专注于乙型肝炎病毒（HBV）和密切相关的丁型肝炎病毒（HDV）。世界上大约25%的人口感染过乙型肝炎病毒。不幸的是，尽管有预防性疫苗，但世界范围内仍出现许多新感染，主要原因是由于成本和其他问题导致疫苗利用不足。此外，对于已经慢性感染乙肝病毒的约3.6亿人（其中约1500万人同时感染丁肝病毒）来说，疫苗没有治疗价值。因此，全世界每年有 0.5 至 100 万人死于 HBV/HDV。因此，乙型肝炎/丁型肝炎研究人员之间继续进行基础研究和科学交流势在必行，而年度乙型肝炎会议就是实现这一目标的场所。 2011年的会议将秉承并加强传统的形式和交流，包括10场口头科学会议、2场海报会议以及结构性较低的“交流”时间。本次会议的特别焦点将是病毒与宿主的相互作用，特别强调细胞生物学、抗病毒免疫和新的治疗靶点。三个主题演讲和一个特别研讨会将促进这一点。与过去一样，我们付出了巨大的努力来尽量减少会议的成本。此外，自 2005 年以来，乙型肝炎基金会坚定承诺支持本次会议，为组织会议提供永久场所，并为其工作人员提供组织会议和宣传会议的机会，特别是向拥有大量代表性不足的大学少数民族。为了让初级和少数族裔研究人员参与，需要 NIH 的支持来帮助支付初级科学家的会议费用。 ） 公共卫生相关性：2011 年乙型肝炎病毒分子生物学会议是自 1985 年以来连续举办的年度系列会议中的下一次预定会议。这是唯一一次将乙型肝炎病毒 (HBV) 领域的基础科学家聚集在一起的权威会议。 ）和来自世界各地的丁型肝炎病毒（HDV）。 HBV 仍然是全球和美国的一个主要公共卫生问题，全世界有超过 3.6 亿人慢性感染，每年有高达 100 万人因 HBV 和 HBV/HDV 引起的肝衰竭、肝硬化和肝细胞癌死亡。该会议是一个重要的、国际公认的平台，可以持续交流乙型肝炎和丁型肝炎感染基础研究的信息。